VisionCare Ophthalmic Technologies Secures $31,000,000 Series E Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba1220c6-2d80-47f3-b4be-b58616dd8e14&Preview=1 -
Date
1/10/2011 -
Company Name
VisionCare Ophthalmic Technologies -
Mailing Address
14395 Saratoga Ave Saratoga, CA 95070 -
Company Description
VisionCare Ophthalmic Technologies (VisionCare) is a privately-held development stage company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. -
Website
http://www.visioncareinc.net -
Transaction Type
Venture Equity -
Transaction Amount
$31,000,000 -
Transaction Round
Series E -
Proceeds Purposes
VisionCare intends to use the new capital to launch its telescope prosthesis for end-stage AMD, the leading cause of blindness in older Americans. -
M&A Terms
-
Venture Investor
Saints Capital -
Venture Investor
Giza Capital -
Venture Investor
Pitango Venture Capital -
Venture Investor
ONSET Ventures -
Venture Investor
Three Arch Partners
